Practice and Consideration over Whole Process Monitoring System for Centralized Drug Procurement Empowered by Big Data

doi:10.19546/j.issn.1674-3830.2022.4.017

China Health Insurance ›› 2022, Vol. 0 ›› Issue (4) : 78-82. DOI: 10.19546/j.issn.1674-3830.2022.4.017

Smart Medical Insurance

Practice and Consideration over Whole Process Monitoring System for Centralized Drug Procurement Empowered by Big Data

Author information +

History +

Abstract

Guided by policies and actual regulatory requirements as well as the idea of closed-loop management, Shenzhen Medicine Trading Platform has built a PDCA whole process monitoring system for centralized drug procurement with big data empowerment. Through big data analysis, closed-loop monitoring technology is realized, monitoring efficiency is improved, and the national centralized procurement task is effectively implemented.

Key words

national centralized drug procurement / PDCA / big data / volume forecast / balance retention policy

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Practice and Consideration over Whole Process Monitoring System for Centralized Drug Procurement Empowered by Big Data[J]. China Health Insurance. 2022, 0(4): 78-82 https://doi.org/10.19546/j.issn.1674-3830.2022.4.017

References

[1] 国家医疗保障局等.《国家医疗保障局等九部门关于国家组织药品集中采购和使用试点扩大区域范围实施意见》[S].医保发〔2019〕56号.
[2] 国务院办公厅.《国务院办公厅关于印发国家组织药品集中采购和使用试点方案的通知》[S].国办发〔2019〕2号.
[3] 国务院办公厅.《国务院办公厅关于推动药品集中带量采购工作常态化制度化开展的意见》[S].(国办发〔2021〕2号).
[4] 《关于国家组织药品集中采购工作中医保资金结余留用的指导意见》(医保发〔2020〕26号).
[5] 王彦予,孟兆敏.大数据驱动下的医保智能监管——基于成都市医保监管实践[J].中国卫生法制,2021,29(05):136-138.